pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 11·1 min read
save

Medicaid to End Funding for Gender-Affirming Surgeries and Hormone Therapy for Transgender Youth

Aug 11, 2026·read at STAT ↗RegulatoryNegative

The Trump administration announced that Medicaid will no longer cover gender-affirming surgeries and hormone treatments for minors.

The change also applies to the Children’s Health Insurance Program, which will stop paying for these services for individuals under 19, though mental-health services will remain covered.

The policy is slated to take effect on Oct. 13. States and private insurers may still choose to provide coverage, and many states have already enacted bans on such care.

The Centers for Medicare and Medicaid Services did not comment on the expected cost impact, and the announcement follows a broader set of actions targeting transgender individuals since the administration returned to office.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Medicaid will stop paying for some gender-affirming care for transgender minors”

read at STAT ↗
662 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.Ultragenyx Pharmaceutical Inc.
topics
Vaccine2MelanomaPsychiatry & CNSRare DiseaseVaccinesmRNA Therapeutic

related stories

  • 2d agoNovo workforce down 13,000BioSpace
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Aug 31STAT+: After a rough stretch, mRNA gets a boost — at least for nowSTAT
  • Aug 28BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancerBioSpace
  • Aug 20Contrasting legal decisions on gender-affirming careSTAT